Sorin Group S.p.A. Receives Approval to Market S5 Heart-Lung Machine in Japan and Announces Landmark Shipment of 7000th Heart-Lung Machine

TOKYO & MILAN, Italy--(BUSINESS WIRE)--The Sorin Group (MIL:SRN), the largest European cardiovascular company and world leader in medical technologies for cardiac surgery, announces that it received the Japanese Pharmaceutical and Medical Devices Agency’s (PMDA) approval to market its Stöckert S5 Heart-Lung Machine in Japan.

MORE ON THIS TOPIC